Lisa Beck is Vice President of Business Development, with responsibility for transactions, alliance management, and strategy. Ms. Beck has nearly 30 years of pharmaceutical and biotech experience across several therapeutic areas including infectious diseases, metabolic diseases, respiratory, dermatology, and rare diseases. She has leadership experience in business development, portfolio management, corporate strategy, alliance management, project management, and clinical development.
Prior to joining Brii Bio, Ms. Beck served as Executive Director, Transactions and Alliance Management at Alexion Pharmaceuticals. Prior to Alexion, she spent 26 years at GSK in roles spanning clinical development to project management, business development, and portfolio management. She has business development transactions experience across multiple therapeutic areas and led and executed well over 50 significant business transactions. Ms. Beck received a B.S. in biology from Vanderbilt University.